Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification

BACKGROUND: In early-stage breast cancer, adjuvant chemotherapy is associated with significant systemic toxicity with only a modest survival benefit. Therefore, there is considerable interest in identifying predictive markers of response to therapy. Doxorubicin, one of the most common drugs used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Betof, A S, Rabbani, Z N, Hardee, M E, Kim, S J, Broadwater, G, Bentley, R C, Snyder, S A, Vujaskovic, Z, Oosterwijk, E, Harris, L N, Horton, J K, Dewhirst, M W, Blackwell, K L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305967/
https://www.ncbi.nlm.nih.gov/pubmed/22333602
http://dx.doi.org/10.1038/bjc.2012.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305967/
https://www.ncbi.nlm.nih.gov/pubmed/22333602
http://dx.doi.org/10.1038/bjc.2012.32

Ejemplares similares